1. Home
  2. SCKT vs NRSN Comparison

SCKT vs NRSN Comparison

Compare SCKT & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Socket Mobile Inc.

SCKT

Socket Mobile Inc.

N/A

Current Price

$0.29

Market Cap

7.7M

Sector

Technology

ML Signal

N/A

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

N/A

Current Price

$1.44

Market Cap

7.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCKT
NRSN
Founded
1992
2017
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
7.6M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SCKT
NRSN
Price
$0.29
$1.44
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $91.75
AVG Volume (30 Days)
★ 668.9K
36.8K
Earning Date
11-04-2026
09-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $15,078,332.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.28
$0.25
52 Week High
$2.79
$7.50

Technical Indicators

Market Signals
Indicator
SCKT
NRSN
Relative Strength Index (RSI) 34.63 31.32
Support Level N/A $0.61
Resistance Level $0.97 $7.50
Average True Range (ATR) 0.05 0.33
MACD -0.02 -0.10
Stochastic Oscillator 11.69 24.85

Price Performance

Historical Comparison
SCKT
NRSN

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the United States, Europe, Asia and Rest of the world, of which the majority of the revenue is generated from the United States.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: